SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041310
Filing Date
2023-08-10
Accepted
2023-08-10 16:08:01
Documents
71
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q spry-20230630.htm   iXBRL 10-Q 2954677
2 EX-10.1 spry-ex10_1.htm EX-10.1 39300
3 EX-31.1 spry-ex31_1.htm EX-31.1 19046
4 EX-31.2 spry-ex31_2.htm EX-31.2 19033
5 EX-32.1 spry-ex32_1.htm EX-32.1 24292
  Complete submission text file 0000950170-23-041310.txt   9081746

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT spry-20230630_pre.xml EX-101.PRE 386813
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT spry-20230630_lab.xml EX-101.LAB 492589
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT spry-20230630_cal.xml EX-101.CAL 43428
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT spry-20230630.xsd EX-101.SCH 67447
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT spry-20230630_def.xml EX-101.DEF 221947
65 EXTRACTED XBRL INSTANCE DOCUMENT spry-20230630_htm.xml XML 1337294
Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Filer) CIK: 0001671858 (see all company filings)

IRS No.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39756 | Film No.: 231159366
SIC: 2834 Pharmaceutical Preparations